Correlation Between Superior Plus and Teva Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Superior Plus and Teva Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Superior Plus and Teva Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Superior Plus Corp and Teva Pharmaceutical Industries, you can compare the effects of market volatilities on Superior Plus and Teva Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Superior Plus with a short position of Teva Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Superior Plus and Teva Pharmaceutical.

Diversification Opportunities for Superior Plus and Teva Pharmaceutical

0.2

Correlation Coefficient

Superior Plus  Teva Pharmaceutical

Modest diversification

The 3 months correlation between Superior and Teva is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Superior Plus Corp and Teva Pharmaceutical Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Teva Pharmaceutical and Superior Plus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Superior Plus Corp are associated (or correlated) with Teva Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Teva Pharmaceutical has no effect on the direction of Superior Plus i.e., Superior Plus and Teva Pharmaceutical go up and down completely randomly.

Pair Corralation between Superior Plus and Teva Pharmaceutical

Assuming the 90 days horizon Superior Plus Corp is expected to generate 0.65 times more return on investment than Teva Pharmaceutical. However, Superior Plus Corp is 1.54 times less risky than Teva Pharmaceutical. It trades about 0.01 of its potential returns per unit of risk. Teva Pharmaceutical Industries is currently generating about -0.17 per unit of risk. If you would invest  412.00  in Superior Plus Corp on December 20, 2024 and sell it today you would lose (2.00) from holding Superior Plus Corp or give up 0.49% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Superior Plus Corp  vs.  Teva Pharmaceutical Industries

Superior Plus Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days Superior Plus Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Superior Plus is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Teva Pharmaceutical

Risk-Adjusted Performance

Very Weak

Over the last 90 days Teva Pharmaceutical Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Superior Plus and Teva Pharmaceutical

The main advantage of trading using opposite Superior Plus and Teva Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Superior Plus position performs unexpectedly, Teva Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Teva Pharmaceutical will offset losses from the drop in Teva Pharmaceutical's long position.

The idea behind Superior Plus Corp and Teva Pharmaceutical Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.